The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression
Open accessAbstract
Seven P2X ion channel nucleotide receptor subtypes have been cloned and characterised. P2X7 receptors (P2X7R) are unusual in that there are extra amino acids in the intracellular C terminus. Low concentrations of ATP open cation channels sometimes leading to cell proliferation, whereas high concentrations of ATP open large pores that release inflammatory cytokines and can lead to apoptotic cell death. Since many diseases involve inflammation and immune responses, and the P2X7R regulates inflammation, there has been recent interest in the pathophysiological roles of P2X7R and the potential of P2X7R antagonists to treat a variety of diseases. These include neurodegenerative diseases, psychiatric disorders, epilepsy and a number of diseases of peripheral organs, including the cardiovascular, airways, kidney, liver, bladder, skin and musculoskeletal. The potential of P2X7R drugs to treat tumour progression is discussed.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
P2X7R-mediated effects, mainly through activation of the neuroinflammatory response, have been involved in MDD, neurodegenerative diseases, schizophrenia, epilepsy, neuropathic pain, and brain injury.
“P2X7R-mediated effects, which mainly occurs through activation of the neuroinflammatory response, have been involved in MDD, neurodegenerative diseases, schizophrenia, epilepsy, neuropathic pain and brain injury [28,66,67,68].”
From P2X7 Receptor Signaling in Stress and Depression (2019) · cites this paper as [66]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Receptors for Purines and Pyrimidines
Burnstock, G., & Verkhratsky, A. (2012) · Springer eBooks · doi:10.1007/978-3-642-28863-0_5 · Cited by 3,973 · see citing works
Self-citationReceptors for Purines and Pyrimidines
Ralevic, V., & Burnstock, G. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01373-5 · Cited by 2,005 · see citing works
Self-citationPhysiology and Pathophysiology of Purinergic Neurotransmission
Burnstock, G. (2007) · Physiological Reviews · doi:10.1152/physrev.00043.2006 · Cited by 1,579 · see citing works
Self-citationThe P2X7 Receptor in Infection and Inflammation
Di Virgilio, F., Dal Ben, D., Sarti, A. C., Giuliani, A. L., & Falzoni, S. (2017) · Immunity · doi:10.1016/j.immuni.2017.06.020 · Cited by 1,267 · see citing works
A P2X purinoceptor expressed by a subset of sensory neurons
Chen, C., Akopian, A. N., Sivilotti, L. G., Colquhoun, D., Burnstock, G., & Wood, J. N. (1995) · Nature · doi:10.1038/377428a0 · Cited by 1,016 · see citing works
Self-citationPathophysiology and Therapeutic Potential of Purinergic Signaling
Burnstock, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.5 · Cited by 609 · see citing works
Self-citationYang, D., He, Y., Muñoz-Planillo, R., Liu, Q., & Núñez, G. (2015) · Immunity · doi:10.1016/j.immuni.2015.10.009 · Cited by 604 · see citing works
Extracellular purines, purinergic receptors and tumor growth
Virgilio, F. D., & Adinolfi, E. (2016) · Oncogene · doi:10.1038/onc.2016.206 · Cited by 555 · see citing works
CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer
Loi, S., Pommey, S., Haibe‐Kains, B., Beavis, P. A., Darcy, P. K., Smyth, M. J., & Stagg, J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222251110 · Cited by 497 · see citing works
Abdulqawi, R., Dockry, R., Holt, K. J., Layton, G. R., McCarthy, B. G., Ford, A. P. D. W., & Smith, J. A. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61255-1 · Cited by 488 · see citing works
Neutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1β secretion in response to ATP
Karmakar, M., Katsnelson, M. A., Dubyak, G. R., & Pearlman, E. (2016) · Nature Communications · doi:10.1038/ncomms10555 · Cited by 450 · see citing works
The P2X7 Receptor Channel: Recent Developments and the Use of P2X7 Antagonists in Models of Disease
Bartlett, R., Stokes, L., & Sluyter, R. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008003 · Cited by 395 · see citing works
P2X7 receptor: an emerging target in central nervous system diseases
Sperlágh, B., & Illes, P. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.08.002 · Cited by 390 · see citing works
Iwata, M., Ota, K. T., Li, X.-Y., Sakaue, F., Li, N., Dutheil, S., Banasr, M., Duric, V., Yamanashi, T., Kaneko, K., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.11.026 · Cited by 387 · see citing works
Sorge, R. E., Trang, T., Dorfman, R., Smith, S. B., Beggs, S., Ritchie, J., Austin, J., Zaykin, D. V., Meulen, H. V., Costigan, M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2710 · Cited by 360 · see citing works
Expression of P2X7 Receptor Increases In Vivo Tumor Growth
Adinolfi, E., Raffaghello, L., Giuliani, A. L., Cavazzini, L., Capece, M., Chiozzi, P., Bianchi, G., Kroemer, G., Pistoia, V., & Virgilio, F. D. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1947 · Cited by 348 · see citing works
Yue, N., Huang, H., Zhu, X., Han, Q., Wang, Y., Li, B., Liu, Q., Wu, G., Zhang, Y., & Yu, J. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0865-y · Cited by 334 · see citing works
Purinergic signalling and cancer
Burnstock, G., & Virgilio, F. D. (2013) · Purinergic Signalling · doi:10.1007/s11302-013-9372-5 · Cited by 319 · see citing works
Self-citationPurinergic signalling and immune cells
Burnstock, G., & Boeynaems, J. M. (2014) · Purinergic Signalling · doi:10.1007/s11302-014-9427-2 · Cited by 310 · see citing works
Self-citationStructural basis for subtype-specific inhibition of the P2X7 receptor
Karasawa, A., & Kawate, T. (2016) · eLife · doi:10.7554/elife.22153 · Cited by 308 · see citing works
P2X7 Receptors: Channels, Pores and More
Volonté, C., Apolloni, S., Skaper, S. D., & Burnstock, G. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712803581137 · Cited by 254 · see citing works
Self-citationPurinergic signaling in the immune system
Virgilio, F. D., & Vuerich, M. (2015) · Autonomic Neuroscience · doi:10.1016/j.autneu.2015.04.011 · Cited by 231 · see citing works
Dı́az-Hernández, M., Diez-Zaera, M., Sánchez‐Nogueiro, J., Gómez‐Villafuertes, R., Canals, J. M., Alberch, J., Miras‐Portugal, M. T., & Lucas, J. J. (2009) · The FASEB Journal · doi:10.1096/fj.08-122275 · Cited by 224 · see citing works
The microglial ATP‐gated ion channel P2X7 as a CNS drug target
Bhattacharya, A., & Biber, K. (2016) · Glia · doi:10.1002/glia.23001 · Cited by 221 · see citing works
P2X ion channel receptors and inflammation
Burnstock, G. (2016) · Purinergic Signalling · doi:10.1007/s11302-015-9493-0 · Cited by 215 · see citing works
Self-citationLack of the purinergic receptor P2X7 results in resistance to contact hypersensitivity
Weber, F. C., Esser, P. R., Müller, T., Ganesan, J., Pellegatti, P., Simon, M. M., Zeiser, R., Idzko, M., Jakob, T., & Martin, S. F. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20092489 · Cited by 209 · see citing works
Zhao, J., Wang, H., Dai, C., Wang, H., Zhang, H., Huang, Y., Wang, S., Gaskin, F., Yang, N., & Fu, S. M. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38174 · Cited by 192 · see citing works
Amoroso, F., Capece, M., Rotondò, A., Cangelosi, D., Ferracin, M., Franceschini, A., Raffaghello, L., Pistoia, V., Varesio, L., & Adinolfi, E. (2015) · Oncogene · doi:10.1038/onc.2014.444 · Cited by 187 · see citing works
Nanobodies that block gating of the P2X7 ion channel ameliorate inflammation
Danquah, W., Meyer‐Schwesinger, C., Rissiek, B., Pinto, C., Prat, A. S., Amadi, M., Iacenda, D., Knop, J., Hammel, A., Bergmann, P., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf8463 · Cited by 182 · see citing works
Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7
Adinolfi, E., Capece, M., Franceschini, A., Falzoni, S., Giuliani, A. L., Rotondo, A., Sarti, A. C., Bonora, M., Syberg, S., Corigliano, D. M., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1259 · Cited by 177 · see citing works
Shemon, A. N., Sluyter, R., Fernando, S. L., Clarke, A. L., Dao‐Ung, L., Skarratt, K. K., Saunders, B. M., Tan, K. S., Gu, B. J., Fuller, S. J., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507816200 · Cited by 173 · see citing works
Tafani, M., Schito, L., Pellegrini, L., Villanova, L., Marfè, G., Anwar, T., Rosa, R., Indelicato, M., Fini, M., Pucci, B., et al. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr101 · Cited by 172 · see citing works
The P2X7 Receptor-Interleukin-1 Liaison
Giuliani, A. L., Sarti, A. C., Falzoni, S., & Di Virgilio, F. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00123 · Cited by 166 · see citing works
Jimenez‐Pacheco, A., Dı́az-Hernández, M., Arribas-Blázquez, M., Sanz‐Rodriguez, A., Olivos-Oré, L. A., Artalejo, A. R., Alves, M., Letavic, M. A., Miras‐Portugal, M. T., Conroy, R. M., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.4009-15.2016 · Cited by 161 · see citing works
P2X7 Receptor Signaling in the Pathogenesis of Smoke-Induced Lung Inflammation and Emphysema
Lucattelli, M., Cicko, S., Müller, T., Lommatzsch, M., Cunto, G. D., Cardini, S., Sundas, W., Grimm, M., Zeiser, R., Dürk, T., et al. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0038oc · Cited by 146 · see citing works
Csóka, B., Németh, Z. H., Törő, G., Idzko, M., Zech, A., Koscsó, B., Spolarics, Z., Antonioli, L., Cseri, K., Erdélyi, K., et al. (2015) · The FASEB Journal · doi:10.1096/fj.15-272450 · Cited by 139 · see citing works
Eser, A., Colombel, J., Rutgeerts, P. J., Vermeire, S., Vogelsang, H., Braddock, M., Persson, T., & Reinisch, W. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000514 · Cited by 138 · see citing works
Hoque, R., Sohail, M. A., Salhanick, S. D., Malik, A. F., Ghani, A., Robson, S. C., & Mehal, W. Z. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00352.2011 · Cited by 138 · see citing works
Territo, P. R., Meyer, J. A., Peters, J. S., Riley, A. K., McCarthy, B. P., Gao, M., Wang, M., Green, M. A., Zheng, Q., & Hutchins, G. D. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.181354 · Cited by 138 · see citing works
Matsumoto, Y., Ohashi, Y., Watanabe, H., & Tsubota, K. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.04.010 · Cited by 137 · see citing works
Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors
Jelassi, B., Anchelin, M., Chamouton, J., Cayuela, M. L., Clarysse, L., Li, J., Goré, J., Jiang, L., & Roger, S. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt099 · Cited by 136 · see citing works
AF‐353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist
Gever, J. R., Soto, R., Henningsen, R. A., Martin, R. S., Hackos, D. H., Panicker, S., Rubas, W., Oglesby, I. B., Dillon, M. P., Milla, M. E., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00796.x · Cited by 132 · see citing works
Self-citationdo Carmo, M. R. S., Menezes, A. P. F., Nunes, A. C. L., Pliássova, A., Rolo, A. P., Palmeira, C. M., Cunha, R. A., Canas, P. M., & de Andrade, G. M. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.01.045 · Cited by 129 · see citing works
Interleukin-1β has trophic effects in microglia and its release is mediated by P2X7R pore
Monif, M., Reid, C. A., Powell, K. L., Drummond, K., O’Brien, T. J., & Williams, D. A. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0621-8 · Cited by 129 · see citing works
Gonçalves, R. G., Gabrich, L., Rosário, A., Takiya, C. M., Ferreira, M. L. L., Chiarini, L. B., Persechini, P. M., Coutinho‐Silva, R., & Leite, M. (2006) · Kidney International · doi:10.1038/sj.ki.5001804 · Cited by 126 · see citing works
Liu, S., Zou, L., Xie, J., Xie, W., Wen, S., Xie, Q., Gao, Y., Li, G., Zhang, C., Xu, C., et al. (2016) · Molecular Brain · doi:10.1186/s13041-016-0226-2 · Cited by 126 · see citing works
Genetics of the P2X7 receptor and human disease
Fuller, S. J., Stokes, L., Skarratt, K. K., Gu, B. J., & Wiley, J. S. (2009) · Purinergic Signalling · doi:10.1007/s11302-009-9136-4 · Cited by 125 · see citing works
Purinergic mechanisms and pain—An update
Burnstock, G. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.078 · Cited by 124 · see citing works
Self-citationPurinergic Signalling and Neurological Diseases: An Update
Burnstock, G. (2017) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527315666160922104848 · Cited by 119 · cited 1× · see citing works
“The control of amyloid plaque formation in vivo by P2X7Rwas reviewed in 2015 [97] and discussed further in 2017 [101].”
Self-citationApolloni, S., Amadio, S., Parisi, C., Matteucci, A., Potenza, R. L., Armida, M., Popoli, P., D’Ambrosi, N., & Volonté, C. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.017038 · Cited by 118 · see citing works
P2X7 receptor stimulates breast cancer cell invasion and migration via the AKT pathway
Xia, J., Yu, X., Tang, L. P., LI, G., & He, T. (2015) · Oncology Reports · doi:10.3892/or.2015.3979 · Cited by 116 · see citing works
Early prostate cancer detected using expression of non‐functional cytolytic P2X7 receptors
Slater, M., Danieletto, S., Gidley-Baird, A. A., Teh, L. C., & Barden, J. A. (2004) · Histopathology · doi:10.1111/j.0309-0167.2004.01798.x · Cited by 116 · see citing works
Inoue, K., Hosoi, J., & Denda, M. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700526 · Cited by 114 · see citing works
Hofman, P. M., Cherfils‐Vicini, J., Bazin, M., Ilié, M., Juhel, T., Hébuterne, X., Gilson, É., Schmid‐Alliana, A., Boyer, O., Adriouch, S., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1778 · Cited by 110 · see citing works
Apolloni, S., Amadio, S., Montilli, C., Volonte, C., & D'Ambrosi, N. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt259 · Cited by 109 · see citing works
Killeen, M. E., Ferris, L. K., Kupetsky, E. A., Falo, L. D., & Mathers, A. R. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202045 · Cited by 109 · see citing works
Neves, A. R., Castelo-Branco, M. T. L., Figliuolo, V. R., Bernardazzi, C., Buongusto, F., Yoshimoto, A., Nanini, H. F., Coutinho, C. M. L. M., Carneiro, A. J. V., Coutinho-Silva, R., et al. (2014) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000441201.10454.06 · Cited by 107 · see citing works
Solini, A., Menini, S., Rossi, C., Ricci, P. C., Santini, E., Fantauzzi, C. B., Iacobini, C., & Pugliese, G. (2013) · The Journal of Pathology · doi:10.1002/path.4237 · Cited by 107 · see citing works
Purinergic receptors as potential therapeutic targets in Alzheimer's disease
Woods, L. T., Ajit, D., Camden, J. M., Erb, L., & Weisman, G. A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.031 · Cited by 106 · see citing works
Chen, X., Hu, J., Jiang, L., Xu, S., Zheng, B., Wang, C., Zhang, J., Wei, X., Chang, L. Y., & Wang, Q. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.08.036 · Cited by 105 · see citing works
Purinergic signaling in kidney disease
Menzies, R. I., Tam, F. W. K., Unwin, R. J., & Bailey, M. A. (2016) · Kidney International · doi:10.1016/j.kint.2016.08.029 · Cited by 105 · see citing works
Jiang, S., Zhang, Y., Zheng, J., Li, X., Yao, Y., Wu, Y., Song, S., Sun, P., Nan, J., & Lian, L. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.11.040 · Cited by 104 · see citing works
Gilbert, S. M., Baird, A. G., Glazer, S., Barden, J. A., Glazer, A., Teh, L. C., & King, J. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15364 · Cited by 104 · see citing works
Purinergic mechanisms in neuroinflammation: An update from molecules to behavior
Beamer, E. H., Gölöncsér, F., Horváth, G., Bekő, K., Otrokocsi, L., Koványi, B., & Sperlágh, B. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.09.019 · Cited by 103 · see citing works
Purinergic receptor P2X7: A novel target for anti-inflammatory therapy
Mehta, N., Kaur, M., Singh, M., Chand, S., Vyas, B., Silakari, P., Bahia, M. S., & Silakari, O. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.10.054 · Cited by 103 · see citing works
Lee, B. H., Hwang, D. M., Palaniyar, N., Grinstein, S., Philpott, D. J., & Hu, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035812 · Cited by 102 · see citing works
Targeting of the P2X7 receptor in pancreatic cancer and stellate cells
Giannuzzo, A., Saccomano, M., Napp, J., Ellegaard, M., Alves, F., & Novak, I. (2016) · International Journal of Cancer · doi:10.1002/ijc.30380 · Cited by 101 · see citing works
Purinergic Signalling: Pathophysiology and Therapeutic Potential
Burnstock, G. (2013) · The Keio Journal of Medicine · doi:10.2302/kjm.2013-0003-re · Cited by 100 · see citing works
Self-citationStructural insights into the competitive inhibition of the ATP-gated P2X receptor channel
Kasuya, G., Yamaura, T., Ma, X., Nakamura, R., Takemoto, M., Nagumo, H., Tanaka, E., Dohmae, N., Nakane, T., Yu, Y., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00887-9 · Cited by 100 · see citing works
P2X7 Receptors Regulate NKT Cells in Autoimmune Hepatitis
Kawamura, H., Aswad, F., Minagawa, M., Govindarajan, S., & Dennert, G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2152 · Cited by 98 · see citing works
Amaral, E. P., Ribeiro, S. C. M., Lanes, V. R., Almeida, F. M., de Andrade, M. R. M., Bomfim, C. C. B., de Salles, É. M., Bortoluci, K. R., Coutinho‐Silva, R., Hirata, M. H., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004188 · Cited by 97 · see citing works
Trophic Activity of Human P2X7 Receptor Isoforms A and B in Osteosarcoma
Giuliani, A. L., Colognesi, D., Ricco, T., Roncato, C., Capece, M., Amoroso, F., Wang, Q., Marchi, E. D., Gartland, A., Virgilio, F. D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107224 · Cited by 97 · see citing works
Critical role of P2X7 receptors in the neuroinflammation and cognitive dysfunction after surgery
Zheng, B., Lai, R., Li, J., & Zuo, Z. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.01.005 · Cited by 97 · see citing works
Purinergic receptors in psychiatric disorders
Krügel, U. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.032 · Cited by 95 · see citing works
ATP Signaling in Brain: Release, Excitotoxicity and Potential Therapeutic Targets
Cisneros-Mejorado, A., Pérez‐Samartín, A., Gottlieb, M., & Matute, C. (2014) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0092-3 · Cited by 93 · see citing works
Purinergic signalling in the kidney in health and disease
Burnstock, G., Evans, L. C., & Bailey, M. A. (2013) · Purinergic Signalling · doi:10.1007/s11302-013-9400-5 · Cited by 92 · see citing works
Self-citationAlves, L. A., Soares‐Bezerra, R. J., Faria, R. X., Ferreira, L., & Frutuoso, V. D. S. (2013) · Molecules · doi:10.3390/molecules180910953 · Cited by 92 · see citing works
P2X7 receptor antagonists: a patent review (2010–2015)
Park, J.-H., & Kim, Y. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2017.1246538 · Cited by 92 · see citing works
Metzger, M. W., Walser, S. M., Aprile-Garcia, F., Dedic, N., Chen, A., Holsboer, F., ARZT, E. S., Wurst, W., & Deussing, J. M. (2016) · Purinergic Signalling · doi:10.1007/s11302-016-9546-z · Cited by 92 · see citing works
P2X7 as a new target for chrysophanol to treat lipopolysaccharide-induced depression in mice
Zhang, K., Liu, J., You, X., Kong, P., Song, Y., Cao, L., Yang, S. T., Wang, W., Fu, Q., & Ma, Z. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.12.043 · Cited by 90 · see citing works
Turner, C. M., Tam, F. W. K., Lai, P., Tarzi, R. M., Burnstock, G., Pusey, C. D., Cook, H. T., & Unwin, R. J. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl589 · Cited by 89 · see citing works
Self-citationAllsopp, R. C., Dayl, S. A., Schmid, R., & Evans, R. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-00732-5 · Cited by 87 · see citing works
Physiopathological Roles of P2X Receptors in the Central Nervous System
Burnstock, G. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867321666140706130415 · Cited by 86 · see citing works
Self-citationFu, W., McCormick, T., Qi, X., Luo, L., Zhou, L., Li, X., Wang, B.-C., Gibbons, H. E., Abdul‐Karim, F. W., & Gorodeski, G. I. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-114 · Cited by 85 · see citing works
Takai, E., Tsukimoto, M., Harada, H., & Kojima, S. (2014) · Purinergic Signalling · doi:10.1007/s11302-014-9411-x · Cited by 85 · see citing works
Ali, S. R., Timmer, A. M., Bilgrami, S., Park, E. J., Eckmann, L., Nizet, V., & Karin, M. (2011) · Immunity · doi:10.1016/j.immuni.2011.04.015 · Cited by 84 · see citing works
Effect of the Purinergic Inhibitor Oxidized ATP in a Model of Islet Allograft Rejection
Vergani, A., Fotino, C., D’Addio, F., Tezza, S., Podetta, M., Gatti, F., Chin, M., Bassi, R., Molano, R. D., Corradi, D., et al. (2013) · Diabetes · doi:10.2337/db12-0242 · Cited by 84 · see citing works
Zhao, H., Zhang, X., Dai, Z., Feng, Y., Li, Q., Zhang, J. H., Liu, X., Chen, Y., & Feng, H. (2016) · Scientific Reports · doi:10.1038/srep23286 · Cited by 84 · see citing works
Extracellular ATP mediates inflammatory responses in colitis via P2 × 7 receptor signaling
Wan, P., Liu, X., Xiong, Y., Ren, Y., Jiang, C., Lü, N., Guo, Y., & Bai, A. (2016) · Scientific Reports · doi:10.1038/srep19108 · Cited by 83 · see citing works
Wang, X., Xie, X., Luo, X., Shang, H., & He, Z. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.6070 · Cited by 83 · see citing works
The role of p2x7 receptor in infectious inflammatory diseases and the influence of ectonucleotidases
Coutinho-Silva, R., Morandini, A., & Savio, L. B. (2014) · Biomedical Journal · doi:10.4103/2319-4170.127803 · Cited by 81 · see citing works
Critical Evaluation of P2X7 Receptor Antagonists in Selected Seizure Models
Fischer, W., Franke, H., Krügel, U., Müller, H., Dinkel, K., Lord, B., Letavic, M. A., Henshall, D. C., & Engel, T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156468 · Cited by 81 · see citing works
Graziano, F., Desdouits, M., Garzetti, L., Podini, P., Alfano, M., Rubartelli, A., Furlan, R., Benaroch, P., & Poli, G. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1500656112 · Cited by 77 · see citing works
Ursu, D., Ebert, P. J., Langron, E., Ruble, C., Munsie, L. M., Zou, W., Fijal, B. A., Qian, Y., McNearney, T. A., Mogg, A. J., et al. (2014) · Molecular Pain · doi:10.1186/1744-8069-10-37 · Cited by 77 · see citing works
P2X7 receptor inhibition protects against ischemic acute kidney injury in mice
Yan, Y., Bai, J., Zhou, X., Tang, J., Jiang, C., Tolbert, E. M., Bayliss, G. P., Gong, R., Zhao, T. C., & Zhuang, S. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00245.2014 · Cited by 77 · see citing works
The evolution of P2X7 antagonists with a focus on CNS indications
Rech, J. C., Bhattacharya, A., Letavic, M. A., & Savall, B. M. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.06.048 · Cited by 77 · see citing works
Xu, P., Xu, Y., Hu, B., Wang, J., Pan, R., Murugan, M., Wu, L., & Tang, Y. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.06.020 · Cited by 76 · see citing works
P2X7 receptor antagonism attenuates the hypertension and renal injury in Dahl salt-sensitive rats
Ji, X., Naito, Y., Hirokawa, G., Weng, H., Hiura, Y., Takahashi, R., & Iwai, N. (2011) · Hypertension Research · doi:10.1038/hr.2011.153 · Cited by 76 · see citing works
P2X and P2Y purinoceptor expression in pancreas from streptozotocin-diabetic rats
Coutinho‐Silva, R., Parsons, M. E., Robson, T., Lincoln, J., & Burnstock, G. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(03)00003-0 · Cited by 75 · see citing works
Self-citationBlockade of P2X7 Receptors or Pannexin-1 Channels Similarly Attenuates Postischemic Damage
Cisneros-Mejorado, A., Gottlieb, M., Cavaliere, F., Magnus, T. U., Koch‐Nolte, F., Scemes, E., Pérez‐Samartín, A., & Matute, C. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.262 · Cited by 75 · see citing works
Figliuolo, V. R., Savio, L. E. B., Safya, H., Nanini, H. F., Bernardazzi, C., Abalo, A., de Souza, H. S. P., Kanellopoulos, J., Bobé, P., Coutinho, C. M. L. M., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.03.004 · Cited by 74 · see citing works
Gu, B. J., Field, J., Dutertre, S., Ou, A., Kilpatrick, T. J., Lechner‐Scott, J., Scott, R. J., Lea, R. A., Taylor, B. V., Stankovich, J. M., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv278 · Cited by 73 · see citing works
Gómez‐Villafuertes, R., García-Huerta, P., Díaz‐Hernandéz, J. I., & Miras‐Portugal, M. T. (2015) · Scientific Reports · doi:10.1038/srep18417 · Cited by 72 · see citing works
P2X7 Receptor Modulates Inflammatory and Functional Pulmonary Changes Induced by Silica
Monção-Ribeiro, L. C., Faffe, D. S., Santana, P. T., Vieira, F. S., da Graça, C. L. A. L., Marques-da-Silva, C., Machado, M. N., Caruso-Neves, C., Zin, W. A., Borojevic, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110185 · Cited by 71 · see citing works
P2 receptors, microglial cytokines and chemokines, and neuropathic pain
Tsuda, M. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23816 · Cited by 71 · see citing works
Inhibition of the P2X7 Receptor Reduces Cystogenesis in PKD
Chang, M., Lu, J., Tian, Y., Chen, Y., Hung, C., Huang, Y.-H., Chen, Y., Wu, M.-S., Yang, C., & Cheng, Y. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010070728 · Cited by 70 · see citing works
Extracellular ATP induces cell death in human intestinal epithelial cells
de Souza, C. O., Santoro, G. F., Figliuolo, V. R., Nanini, H. F., de Souza, H. S. P., Castelo-Branco, M. T. L., Abalo, A., Paiva, M. M., Coutinho, C. M. L. M., & Coutinho‐Silva, R. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.08.013 · Cited by 69 · see citing works
Hu, H., Yang, B., Li, Y., Zhang, S., & Li, Z. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2770 · Cited by 69 · see citing works
Avendaño, B. C., Montero, T. D., Chávez, C. E., Rommy von Bernhardi, M., & Orellana, J. A. (2015) · Glia · doi:10.1002/glia.22877 · Cited by 67 · see citing works
Purinergic Signaling in Gut Inflammation: The Role of Connexins and Pannexins
Diezmos, E. F., Bertrand, P. P., & Liu, L. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00311 · Cited by 67 · see citing works
Avanzato, D., Genova, T., Fiorio, A., Bernardini, M., Bianco, S., Bussolati, B., Mancardi, D., Giraudo, E., Maione, F., Cassoni, P., et al. (2016) · Scientific Reports · doi:10.1038/srep32602 · Cited by 67 · see citing works
Motor neuron dysfunction in a mouse model of ALS: Gender-dependent effect of P2X7 antagonism
Cervetto, C., Frattaroli, D., Maura, G., & Marcoli, M. (2013) · Toxicology · doi:10.1016/j.tox.2013.04.004 · Cited by 66 · see citing works
Sinadinos, A., Young, C., Al-khalidi, R. A. A., Teti, A. M., Kaliński, P., Mohamad, S., Floriot, L., Henry, T., Tozzi, G., Jiang, T., et al. (2015) · PLoS Medicine · doi:10.1371/journal.pmed.1001888 · Cited by 65 · see citing works
Mishra, A., Guo, Y., Zhang, L., More, S., Weng, T., Chintagari, N. R., Huang, C., Liang, Y., Pushparaj, S., Gou, D., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501041 · Cited by 65 · see citing works
Xie, Y., Williams, C. D., McGill, M. R., Lebofsky, M., Ramachandran, A., & Jaeschke, H. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs283 · Cited by 64 · see citing works
P2X7 Receptor Signaling Contributes to Sepsis-Associated Brain Dysfunction
Savio, L. E. B., Andrade, M. G. J., de Andrade Mello, P., Santana, P. T., Moreira-Souza, A. C. A., Kolling, J., Longoni, A., Feldbrügge, L., Wu, Y., Wyse, A. T. S., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0168-9 · Cited by 64 · see citing works
Jp, M., Silva, R. B. M., Coutinho‐Silva, R., Takiya, C. M., Battastini, A., Morrone, F. B., & Campos, M. M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01535.x · Cited by 63 · see citing works
Antonioli, L., Giron, M. C., Colucci, R., Pellegrini, C., Sacco, D., Caputi, V., Orso, G., Tuccori, M., Scarpignato, C., Blandizzi, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0116253 · Cited by 63 · see citing works
Lipopolysaccharide-induced lung injury: Role of P2X7 receptor
Monção-Ribeiro, L. C., Cagido, V. R., Lima-Murad, G., Santana, P. T., Riva, D. R., Borojević, R., Zin, W. A., Cavalcante, M. C. M., Riça, I. G., Brando-Lima, A. C., et al. (2011) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2011.09.015 · Cited by 62 · see citing works
Şeref-Ferlengez, Z., Maung, S., Schaffler, M. B., Spray, D. C., Suadicani, S. O., & Thi, M. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155107 · Cited by 60 · see citing works
Schneider, G., Glaser, T., Lameu, C., Abdelbaset‐Ismail, A., Sellers, Z. P., Moniuszko, M., Ulrich, H., & Ratajczak, M. Z. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0469-z · Cited by 59 · see citing works
Purinergic receptors P2RX4 and P2RX7 in familial multiple sclerosis
Sadovnick, A. D., Gu, B. J., Traboulsee, A. L., Bernales, C. Q., Encarnacion, M. J., Yee, I. M. L., Criscuoli, M. G., Huang, X., Ou, A., Milligan, C. J., et al. (2017) · Human Mutation · doi:10.1002/humu.23218 · Cited by 58 · see citing works
da Silva, M. V., Marosti, A. R., Mendes, C. E., Palombit, K., & Castelucci, P. (2014) · Histochemistry and Cell Biology · doi:10.1007/s00418-014-1270-6 · Cited by 57 · see citing works
Murphy, N., Cowley, T. R., Richardson, J. C., Virley, D. J., Upton, N., Walter, D. S., & Lynch, M. A. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00531.x · Cited by 56 · see citing works
Feasibility study of B16 melanoma therapy using oxidized ATP to target purinergic receptor P2X7
Hattori, F., Ohshima, Y., Seki, S., Tsukimoto, M., Sato, M., Takenouchi, T., Suzuki, A., Takai, E., Kitani, H., Harada, H., et al. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.09.001 · Cited by 55 · see citing works
Ma, M., Ren, Q., Zhang, J.-C., & Hashimoto, K. (2014) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2014.12.1.31 · Cited by 55 · see citing works
Renal P2 receptors and hypertension
Menzies, R. I., Unwin, R. J., & Bailey, M. A. (2014) · Acta Physiologica · doi:10.1111/apha.12412 · Cited by 55 · see citing works
Altered responsiveness to extracellular ATP enhances acetaminophen hepatotoxicity
Amaral, S. S., de Oliveira, A. G., Marques, P. E., Quintão, J. L. D., Pires, D. A., Resende, R. R., de Sousa, B. R., Melgaço, J. G., Pinto, M. A., Russo, R. C., et al. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-10 · Cited by 55 · see citing works
Tu, G., Zou, L., Liu, S., Wu, B., Lv, Q., Wang, S., Xue, Y., Zhang, C., Yi, Z., Zhang, X., et al. (2016) · Purinergic Signalling · doi:10.1007/s11302-016-9518-3 · Cited by 55 · see citing works
Salvestrini, V., Orecchioni, S., Talarico, G., Reggiani, F., Mazzetti, C., Bertolini, F., Orioli, E., Adinolfi, E., Virgilio, F. D., Pezzi, A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13927 · Cited by 55 · see citing works
Atypical P2X7receptor pharmacology in two human osteoblast‐like cell lines
Alqallaf, S. M., Evans, B., & Kidd, E. J. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00119.x · Cited by 54 · see citing works
Astrocytes mediate HIV‐1 Tat‐induced neuronal damage via ligand‐gated ion channel P2X7R
Tewari, M., Monika, Varghese, R. K., Menon, M. R., & Seth, P. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12953 · Cited by 54 · see citing works
Xie, J., Liu, S., Wu, B., Li, G., Rao, S., Zou, L., Yi, Z., Zhang, C., Jia, T., Zhao, S., et al. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.12.006 · Cited by 54 · see citing works
Sustained activation of P2X7 induces MMP-2-evoked cleavage and functional purinoceptor inhibition
Young, C., Chira, N., Róg, J., Al-khalidi, R. A. A., Bénard, M., Galas, L., Chan, P., Vaudry, D., Zabłocki, K., & Górecki, D. C. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx030 · Cited by 53 · see citing works
Sun, L., Gao, J., Zhao, M., Cui, J., Li, Y., Yang, X., Jing, X., & Wu, Z. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.05.049 · Cited by 52 · see citing works
Contraction of intestinal effector T cells by retinoic acid-induced purinergic receptor P2X7
Hashimoto‐Hill, S., Friesen, L., Kim, M., & Kim, C. H. (2016) · Mucosal Immunology · doi:10.1038/mi.2016.109 · Cited by 52 · see citing works
Gazzerro, E., Baldassari, S., Assereto, S., Fruscione, F., Pistorio, A., Panicucci, C., Volpi, S., Perruzza, L., Fiorillo, C., Minetti, C., et al. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.08.010 · Cited by 51 · see citing works
Caseley, E. A., Muench, S. P., Roger, S., Mao, H., Baldwin, S. A., & Jiang, L. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150813344 · Cited by 51 · see citing works
Santana, P. T., Benjamim, C. F., Martinez, C. G., Kurtenbach, E., Takiya, C. M., & Coutinho‐Silva, R. (2015) · Journal of Innate Immunity · doi:10.1159/000371388 · Cited by 51 · see citing works
Baudelet, D., Lipka, E., Millet, R., & Ghinet, A. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666141212120926 · Cited by 51 · see citing works
Bergamin, L. S., Braganhol, E., Figueiró, F., Casali, É. A., Zanin, R. F., Sévigny, J., & Battastini, A. M. O. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25018 · Cited by 50 · see citing works
Sáez-Orellana, F., Godoy, P. A., Bastidas, C. Y., Silva-Grecchi, T., Guzmán, L., Aguayo, L. G., & Fuentealba, J. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.04.005 · Cited by 50 · see citing works
Calcium Channels and Associated Receptors in Malignant Brain Tumor Therapy
Morrone, F. B., Gehring, M. P., & Nicoletti, N. F. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.103770 · Cited by 50 · see citing works
Purinergic receptors: new targets for the treatment of gout and fibrosis
Gicquel, T., Daré, B. L., Boichot, E., & Lagente, V. (2016) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12256 · Cited by 50 · see citing works
Bartlett, R., Sluyter, V., Watson, D., Sluyter, R., & Yerbury, J. J. (2017) · PeerJ · doi:10.7717/peerj.3064 · Cited by 50 · see citing works
Garg, A. D., Krysko, D. V., Vandenabeele, P., & Agostinis, P. (2016) · Cell Death and Disease · doi:10.1038/cddis.2015.411 · Cited by 49 · see citing works
P2X7 receptor as predictor gene for glioma radiosensitivity and median survival
Gehring, M. P., Kipper, F. C., Nicoletti, N. F., Sperotto, N. D. D. M., Zanin, R. F., Tamajusuku, A. S. K., Flores, D. G., Meurer, L., Roesler, R., Filho, A. B., et al. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.09.001 · Cited by 48 · see citing works
The effects of P2X7 receptor antagonists on the formation and function of human osteoclasts in vitro
Agrawal, A., Buckley, K. M., Bowers, K. C., Furber, M., Gallagher, J. A., & Gartland, A. (2010) · Purinergic Signalling · doi:10.1007/s11302-010-9181-z · Cited by 48 · see citing works
Bhave, S. M., Gade, A. R., Kang, M., Hauser, K. F., Dewey, W. L., & Akbarali, H. I. (2017) · The FASEB Journal · doi:10.1096/fj.201601068r · Cited by 48 · see citing works
The role of P2X7 receptors in tissue fibrosis: a brief review
Gentile, D., Natale, M., Lazzerini, P. E., Capecchi, P. L., & Pasini, F. L. (2015) · Purinergic Signalling · doi:10.1007/s11302-015-9466-3 · Cited by 47 · see citing works
Role of the purinergic signaling in epilepsy
Cieślak, M., Wojtczak, A., & Komoszyński, M. (2016) · Pharmacological Reports · doi:10.1016/j.pharep.2016.09.018 · Cited by 47 · see citing works
Leyva-Grado, V. H., Ermler, M. E., Schotsaert, M., Gonzalez, M. G., Gillespie, V., Lim, J. K., & García-Sastre, A. (2017) · mBio · doi:10.1128/mbio.00229-17 · Cited by 47 · see citing works
Effects of P2X7 receptor antagonists on hypoxia-induced neonatal seizures in mice
Rodriguez-Alvarez, N., Jimenez-Mateos, E. M., Engel, T., Quinlan, S., Reschke, C. R., Conroy, R. M., Bhattacharya, A., Boylan, G. B., & Henshall, D. C. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.01.005 · Cited by 46 · see citing works
Greve, A., Skals, M., Fagerberg, S. K., Tonnus, W., Ellermann‐Eriksen, S., Evans, R. J., Linkermann, A., & Prætorius, H. A. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00113 · Cited by 46 · see citing works
Park, J., Williams, D. R., Lee, J., Lee, S., Lee, J., Ko, H., Lee, G.-E., Kim, S., Lee, J. M., Abdelrahman, A., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01690 · Cited by 45 · see citing works
Du, D., Jiang, M., Liu, M., Wang, J., Xia, C., Guan, R., Shen, L., Ji, Y., & Zhu, D. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.12.026 · Cited by 44 · see citing works
Medicinal Chemistry of P2X Receptors: Allosteric Modulators
Müller, C. E. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666141210155610 · Cited by 44 · see citing works
Portales‐Cervantes, L., Niño-Moreno, P., Salgado‐Bustamante, M., García-Hernández, M. H., Baranda-Candido, L., Reynaga-Hernández, E., Barajas‐López, C., González‐Amaro, R., & Portales‐Pérez, D. P. (2012) · Cellular Immunology · doi:10.1016/j.cellimm.2012.05.005 · Cited by 44 · see citing works
Wu, B., Zhang, C., Zou, L., Ma, Y., Huang, K., Lv, Q., Zhang, X., Wang, S., Xue, Y., Yi, Z., et al. (2016) · Autonomic Neuroscience · doi:10.1016/j.autneu.2016.04.001 · Cited by 44 · see citing works
Submucosal neurons and enteric glial cells expressing the P2X7 receptor in rat experimental colitis
da Silva, M. V., Marosti, A. R., Mendes, C. E., Palombit, K., & Castelucci, P. (2017) · Acta Histochemica · doi:10.1016/j.acthis.2017.05.001 · Cited by 44 · see citing works
Rozmer, K., Gao, P., Araújo, M. G. L., Khan, M. T., Liu, J., Rong, W., Tang, Y., Franke, H., Krügel, U., Fernandes, M. J. D. S., et al. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw178 · Cited by 43 · see citing works
Functional polymorphisms in the P2X7 receptor gene are associated with stress fracture injury
Varley, I., Greeves, J. P., Sale, C., Friedman, E., Moran, D. S., Yanovich, R., Wilson, P. J., Gartland, A., Hughes, D. C., Stellingwerff, T., et al. (2016) · Purinergic Signalling · doi:10.1007/s11302-016-9495-6 · Cited by 42 · see citing works
P2X7 receptor-mediated analgesia in cancer-induced bone pain
Falk, S., Schwab, S., Frøsig-Jørgensen, M., Clausen, R. P., Dickenson, A. H., & Heegaard, A. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.02.011 · Cited by 41 · see citing works
Chandrashekaran, V., Das, S., Seth, R. K., Dattaroy, D., Alhasson, F. A., Michelotti, G. A., Nagarkatti, M., Nagarkatti, P. S., Diehl, A. M., & Chatterjee, S. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.10.009 · Cited by 40 · see citing works
Corrêa, G., Lindenberg, C. D. A., Fernandes-Santos, C., Gandini, M., de Paiva, F. P., Coutinho‐Silva, R., & Kubelka, C. F. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.02.003 · Cited by 40 · see citing works
miR-9 Mediates CALHM1-Activated ATP-P2X7R Signal in Painful Diabetic Neuropathy Rats
Liu, W., Ao, Q., Guo, Q., He, W., Peng, L., Jiang, J., & Hu, X. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9700-1 · Cited by 39 · see citing works
Inflammatory early events associated to the role of P2X7 receptor in acute murine toxoplasmosis
Corrêa, G., Lindenberg, C. D. A., Moreira-Souza, A. C. A., Savio, L. E. B., Takiya, C. M., Marques-da-Silva, C., Vommaro, R. C., & Coutinho‐Silva, R. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.12.007 · Cited by 39 · see citing works
P2X 7 -mediated chemoprevention of epithelial cancers
Gorodeski, G. I. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903277249 · Cited by 38 · see citing works
Rodrigues, A. M., Bergamaschi, C. T., Fernandes, M. J. D. S., Paredes‐Gamero, E. J., Curi, M. V., Ferreira, A. T., Araújo, S., Punaro, G., Maciel, F. R., Nogueira, G. B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097452 · Cited by 38 · see citing works
Purinergic signalling in autoimmunity: A role for the P2X7R in systemic lupus erythematosus?
Virgilio, F. D., & Giuliani, A. L. (2016) · Biomedical Journal · doi:10.1016/j.bj.2016.08.006 · Cited by 38 · see citing works
D’Alimonte, I., Nargi, E., Zuccarini, M., Lanuti, P., Iorio, P. D., Giuliani, P., Ricci‐Vitiani, L., D, R. P. M., Caciagli, F., & Ciccarelli, R. (2015) · Purinergic Signalling · doi:10.1007/s11302-015-9454-7 · Cited by 37 · see citing works
Sociali, G., Visigalli, D., Prukop, T., Cervellini, I., Mannino, E., Venturi, C. B., Bruzzone, S., Sereda, M. W., & Schenone, A. E. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.017 · Cited by 37 · see citing works
Figliuolo, V. R., Chaves, S. P., Savio, L. E. B., Thorstenberg, M. L., de Salles, É. M., Takiya, C. M., Lima, M. R. D., Guedes, H. L. D. M., Rossi‐Bergmann, B., & Coutinho‐Silva, R. (2016) · Purinergic Signalling · doi:10.1007/s11302-016-9544-1 · Cited by 37 · see citing works
Liu, Z., Liu, Y., Xu, L., An, H., Chang, Y., Yang, Y., Zhang, W., & Xu, J. (2015) · Cancer Science · doi:10.1111/cas.12736 · Cited by 35 · see citing works
Miras‐Portugal, M. T., Díaz‐Hernandéz, J. I., Gómez‐Villafuertes, R., Dı́az-Hernández, M., Artalejo, A. R., & Gualix, J. (2015) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2015.02.005 · Cited by 33 · see citing works
Purinergic Receptors: Key Mediators of HIV-1 Infection and Inflammation
Swartz, T. H., Dubyak, G., & Chen, B. K. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00585 · Cited by 33 · see citing works
Jörg, M., Scammells, P. J., & Capuano, B. (2014) · Current Medicinal Chemistry · doi:10.2174/1389200215666140217110716 · Cited by 32 · see citing works
P2X7 receptor knockout prevents streptozotocin-induced type 1 diabetes in mice
Vieira, F. S., Nanini, H. F., Takiya, C. M., & Coutinho‐Silva, R. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.10.008 · Cited by 31 · see citing works
A Purinergic Trail for Metastases
Ferrari, D., Malavasi, F., & Antonioli, L. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.11.010 · Cited by 31 · see citing works
Franco, M., Bautista‐Pérez, R., Cano-Martı́nez, A., Pacheco, U., Santamaría, J., del Valle‐Mondragón, L., Pérez-Méndez, O. A., & Navar, L. G. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00663.2016 · Cited by 31 · see citing works
P2X7 mRNA expression in non-small cell lung cancer: MicroRNA regulation and prognostic value
Boldrini, L., Giordano, M., Alì, G., Melfi, F. M. A., Romano, G., Lucchi, M., & Fontanini, G. (2014) · Oncology Letters · doi:10.3892/ol.2014.2620 · Cited by 30 · see citing works
The P2X7 Receptor: A Key Player in Immune-Mediated Bone Loss?
Kvist, T., Schwarz, P., & Jørgensen, N. R. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/954530 · Cited by 29 · see citing works
Zhang, J., Li, X., Gao, Y., Guo, G., Xu, C., Li, G., Liu, S., Huang, A., Tu, G., Peng, H., et al. (2012) · Burns · doi:10.1016/j.burns.2012.08.013 · Cited by 29 · see citing works
Role of P2Y12 Receptor in Thrombosis
Zhang, Y., Zhang, S., & Ding, Z. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_123 · Cited by 29 · see citing works
Purinergic signaling during Porphyromonas gingivalis infection
Almeida-da-Silva, C. L. C., Morandini, A. C., Ulrich, H., Ojcius, D. M., & Coutinho‐Silva, R. (2016) · Biomedical Journal · doi:10.1016/j.bj.2016.08.003 · Cited by 29 · see citing works
Role of P2X7 receptor in Clostridium perfringens beta-toxin-mediated cellular injury
Nagahama, M., Seike, S., Shirai, H., Takagishi, T., Kobayashi, K., Takehara, M., & Sakùrai, J. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.08.011 · Cited by 28 · see citing works
Fang, J., Chen, X., Wang, S., Xie, T., Du, X., Liu, H., Wang, S., Li, X., Chen, J., Zhang, B., et al. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1016663 · Cited by 27 · see citing works
Beswick, P., Billinton, A., Chambers, L. J., Dean, D. K., Fonfría, E., Gleave, R. J., Medhurst, S. J., Michel, A. D., Moses, A. P., Patel, S., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.05.107 · Cited by 27 · see citing works
Mrázek, F., Gallo, J., Stahelova, A., & Petřek, M. (2009) · Human Immunology · doi:10.1016/j.humimm.2009.10.013 · Cited by 27 · see citing works
Human β Defensin-3 Increases CD86 Expression on Monocytes by Activating the ATP-Gated Channel P2X7
Lioi, A. B., Ferrari, B., Dubyak, G., Weinberg, A., & Sieg, S. F. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401319 · Cited by 27 · see citing works
Catanzaro, J. M., Hueston, C. M., Deak, M. M., & Deak, T. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000072 · Cited by 27 · see citing works
P2X7 receptors are a potential novel target for anti-glioma therapies
Monif, M., O'Brien, T. J., Drummond, K. J., Reid, C. A., Liubinas, S. V., & Williams, D. A. (2014) · Journal of Inflammation · doi:10.1186/s12950-014-0025-4 · Cited by 26 · see citing works
Muñoz, A., Yazdi, I. K., Tang, X., Rivera, C., Taghipour, N., Grossman, R. G., Boone, T. B., & Tasciotti, E. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.12.017 · Cited by 26 · see citing works
P2X7 Antagonists for CNS Indications: Recent Patent Disclosures
Pevarello, P., Bovolenta, S., Tarroni, P., Za, L., Severi, E., Torino, D., & Vitalone, R. (2017) · Pharmaceutical Patent Analyst · doi:10.4155/ppa-2016-0044 · Cited by 26 · see citing works
Co-Expression of Wild-Type P2X7R with Gln460Arg Variant Alters Receptor Function
Aprile-Garcia, F., Metzger, M. W., Páez-Pereda, M., Stadler, H., Acuña, M., Liberman, A. C., Senin, S. A., Gerez, J., Hoijman, E., Refojo, D., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151862 · Cited by 25 · see citing works
Role of P2X Purinoceptor 7 in Neurogenic Pulmonary Edema after Subarachnoid Hemorrhage in Rats
Chen, S., Zhu, Z., Klebe, D. W., Bian, H., Krafft, P. R., Tang, J., Zhang, J., & Zhang, J. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089042 · Cited by 24 · see citing works
Zempo, H., Sugita, Y., Ogawa, M., Watanabe, R., Suzuki, J., & Isobe, M. (2014) · Heart and Vessels · doi:10.1007/s00380-014-0527-2 · Cited by 24 · see citing works
Martinez, C. G., Zamith‐Miranda, D., da Silva, M. G., Ribeiro, K. C., Brandão, I. T., Silva, C. L., Diaz, B. L., Bellio, M., Persechini, P. M., & Kurtenbach, E. (2015) · Scientific Reports · doi:10.1038/srep16940 · Cited by 24 · see citing works
McHugh, S. M., Roman, S. A., Davis, B. G., Koch, A., Pickett, A. M., Richardson, J. C., Miller, S. R., Wetten, S., Cox, C. J., Karpe, F., et al. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04200.x · Cited by 23 · see citing works
Pool, L. R., Wagner, R. M., Scott, L. L., Roychowdhury, D., Berhane, R., Wu, C., Pearson, K., Sutton, J. A., & Schaffer, W. T. (2015) · The FASEB Journal · doi:10.1096/fj.14-264358 · Cited by 23 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Extracellular ATP and P2 purinergic signalling in the tumour microenvironment
Virgilio, F. D., Sarti, A. C., Falzoni, S., Marchi, E. D., & Adinolfi, E. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0037-0 · Cited by 730 · see citing works
The Role of Inflammation in the Pathogenesis of Osteoarthritis
Chow, Y. Y., & Chin, K. (2020) · Mediators of Inflammation · doi:10.1155/2020/8293921 · Cited by 536 · see citing works
Grams, R. J., Santos, W. L., Scorei, I. R., Abad-García, A., Rosenblum, C. A., Biţă, A., Cerecetto, H., Viñas, C., & Soriano-Ursua, M. A. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00663 · Cited by 389 · see citing works
Interleukin-1β is a potential therapeutic target for periodontitis: a narrative review
Cheng, R., Wu, Z., Li, M., Shao, M., & Hu, T. (2020) · International Journal of Oral Science · doi:10.1038/s41368-019-0068-8 · Cited by 304 · see citing works
Microglia in Alzheimer’s disease: pathogenesis, mechanisms, and therapeutic potentials
Miao, J., Ma, H., Yang, Y., Liao, Y., Lin, C., Zheng, J., Yu, M., & Lan, J. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1201982 · Cited by 293 · see citing works
Full-Length P2X7 Structures Reveal How Palmitoylation Prevents Channel Desensitization
McCarthy, A. E., Yoshioka, C., & Mansoor, S. (2019) · Cell · doi:10.1016/j.cell.2019.09.017 · Cited by 259 · see citing works
Thawkar, B. S., & Kaur, G. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.11.010 · Cited by 247 · see citing works
P2X7 Interactions and Signaling – Making Head or Tail of It
Kopp, R., Krautloher, A., Ramírez-Fernández, A., & Nicke, A. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00183 · Cited by 217 · see citing works
Targeting Adenosine Receptor Signaling in Cancer Immunotherapy
Sek, K., Mølck, C., Stewart, G. D., Kats, L. M., Darcy, P. K., & Beavis, P. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123837 · Cited by 204 · see citing works
Eisinger, S., Sarhan, D., Boura, V. F., Ibarlucea-Benitez, I., Tyystjärvi, S., Oliynyk, G., Arsenian‐Henriksson, M., Lane, D. P., Wickström, S. L., Kiessling, R. W., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2015343117 · Cited by 173 · see citing works
P2X7 Receptor Signaling in Stress and Depression
Ribeiro, D. E., Roncalho, A. L., Glaser, T., Ulrich, H., Wegener, G., & Joca, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112778 · Cited by 129 · see citing works
Wei, F., Wang, D., Wei, J., Tang, N., Tang, L. M., Xiong, F., Guo, C. J., Zhou, M., Li, X., Li, G., et al. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03581-0 · Cited by 128 · see citing works
Mechanosensitive ion channels push cancer progression
Pethő, Z., Najder, K., Bulk, E., & Schwab, A. (2019) · Cell Calcium · doi:10.1016/j.ceca.2019.03.007 · Cited by 125 · see citing works
Animal models of pain: Diversity and benefits
Abboud, C., Duveau, A., Bouali‐Benazzouz, R., Massé, K. L., Mattar, J., Brochoire, L., Fossat, P., Boué‐Grabot, É., Hleihel, W., & Landry, M. (2020) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2020.108997 · Cited by 112 · see citing works
Wang, H., Wang, X., Xu, L., Zhang, J., & Cao, H. (2020) · Purinergic Signalling · doi:10.1007/s11302-020-09711-4 · Cited by 104 · see citing works
CD73 Downregulation Decreases In Vitro and In Vivo Glioblastoma Growth
Azambuja, J. H., Gelsleichter, N. E., Beckenkamp, L. R., Iser, I. C., Fernandes, M. D. C., Figueiró, F., Battastini, A. M. O., Scholl, J. N., de Oliveira, F. H., Spanevello, R. M., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1240-4 · Cited by 96 · see citing works
P2RX7 Purinoceptor as a Therapeutic Target—The Second Coming?
Young, C., & Górecki, D. C. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00248 · Cited by 95 · see citing works
Rotondo, J. C., Mazziotta, C., Lanzillotti, C., Stefani, C., Badiale, G., Campione, G., Martini, F., & Tognon, M. G. (2022) · Cancers · doi:10.3390/cancers14051116 · Cited by 94 · see citing works
The P2X7 Receptor in Microglial Cells Modulates the Endolysosomal Axis, Autophagy, and Phagocytosis
Campagno, K. E., & Mitchell, C. H. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.645244 · Cited by 90 · see citing works
Extracellular ATP and Adenosine in Cancer Pathogenesis and Treatment
Chiarella, A. M., Ryu, Y. K., Manji, G. A., & Rustgi, A. K. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.04.008 · Cited by 84 · see citing works
Inherent P2X7 Receptors Regulate Macrophage Functions during Inflammatory Diseases
Ren, W.-J., Rubini, P., Tang, Y., Engel, T., & Illés, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010232 · Cited by 70 · see citing works
Blocking P2X7-Mediated Macrophage Polarization Overcomes Treatment Resistance in Lung Cancer
Qin, J., Zhang, X., Tan, B., Zhang, S., Yin, C., Xue, Q., Zhang, Z., Ren, H., Chen, J., Liu, M., et al. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0123 · Cited by 80 · see citing works
Nociceptive signaling mediated by P2X3, P2X4 and P2X7 receptors
Inoue, K., & Tsuda, M. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114309 · Cited by 78 · see citing works
Pathological ATPergic Signaling in Major Depression and Bipolar Disorder
Illés, P., Verkhratsky, A., & Tang, Y. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00331 · Cited by 77 · see citing works
Campagno, K. E., Lu, W., Jassim, A. H., Albalawi, F., Cenaj, A., Tso, H., Clark, S. P., Sripinun, P., Gómez, N. M., & Mitchell, C. H. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02251-7 · Cited by 67 · see citing works
The role and pharmacological properties of the P2X7 receptor in neuropathic pain
Zhang, W., Zhu, J., & Liu, Z.-X. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.11.006 · Cited by 67 · see citing works
Structural and Functional Basis for Understanding the Biological Significance of P2X7 Receptor
Martínez-Cuesta, M. Á., Blanch‐Ruiz, M. A., Ortega‐Luna, R., Sánchez‐López, A., & Álvarez, Á. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228454 · Cited by 62 · see citing works
The pharmacological and pharmacokinetic properties of esculin: A comprehensive review
Li, C., Li, J.-C., Lai, J., & Liu, Y. (2022) · Phytotherapy Research · doi:10.1002/ptr.7470 · Cited by 61 · see citing works
Guan, S., Shen, Y., Ge, H., Xiong, W., He, L., Liu, L., Yin, C., Wei, X., & Gao, Y. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00770 · Cited by 60 · see citing works
Irradiation causes senescence, ATP release, and P2X7 receptor isoform switch in glioblastoma
Zanoni, M., Sarti, A. C., Zamagni, A., Cortesi, M., Pignatta, S., Arienti, C., Tebaldi, M., Sarnelli, A., Romeo, A., Bartolini, D., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04526-0 · Cited by 58 · see citing works
Price, G. W., Chadjichristos, C. E., Kavvadas, P., Tang, S. C. W., Yiu, W. H., Green, C. R., Potter, J. A., Siamantouras, E., Squires, P. E., & Hills, C. E. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00558-1 · Cited by 58 · see citing works
Orchestrated modulation of rheumatoid arthritis via crosstalking intracellular signaling pathways
Ibrahim, S. S. A., & Huttunen, K. M. (2021) · Inflammopharmacology · doi:10.1007/s10787-021-00800-3 · Cited by 56 · see citing works
Antagonism of the ATP-gated P2X7 receptor: a potential therapeutic strategy for cancer
Drill, M., Jones, N. C., Hunn, M., O'Brien, T. J., & Monif, M. (2021) · Purinergic Signalling · doi:10.1007/s11302-021-09776-9 · Cited by 52 · see citing works
Sidoryk‐Wȩgrzynowicz, M., & Strużyńska, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168404 · Cited by 51 · see citing works
P2X7 receptor in inflammation and pain
Hu, S.-Q., Hu, J., Zou, F.-L., Liu, J., Luo, H., Hu, D.-X., Wu, L., & Zhang, W. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.07.006 · Cited by 50 · see citing works
Victoni, T., Barreto, E., Lagente, V., & Carvalho, V. F. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6646923 · Cited by 54 · see citing works
The progress and prospects of targeting the adenosine pathway in cancer immunotherapy
Yang, Y., Zhu, L., Xu, Y., Liang, L., Liu, L.-Z., Chen, X., Li, H., & Liu, H. (2025) · Biomarker Research · doi:10.1186/s40364-025-00784-0 · Cited by 50 · see citing works
Yang, C., Shi, S., Su, Y., Tong, J., & Li, L. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15708 · Cited by 50 · see citing works
Role of the P2X7 receptor in the pathogenesis of type 2 diabetes and its microvascular complications
Solini, A., & Novak, I. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.02.009 · Cited by 48 · see citing works
Williams, B. M., Cliff, C. L., Lee, K., Squires, P. E., & Hills, C. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.907504 · Cited by 43 · see citing works
Novel biologics targeting the P2X7 ion channel.
Koch-Nolte, F., Eichhoff, A., Pinto-Espinoza, C., Schwarz, N., Schäfer, T., Menzel, S., Haag, F., Demeules, M., Gondé, H., & Adriouch, S. (2019) · Current opinion in pharmacology (Print) · doi:10.1016/j.coph.2019.03.001 · Cited by 44 · see citing works
P2X7R antagonists in chronic stress-based depression models: a review
von Mücke-Heim, I.-A., Ries, C., Urbina-Treviño, L., & Deussing, J. M. (2021) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01306-3 · Cited by 46 · see citing works
Li, Y., Chen, J., Bolinger, A. A., Chen, H., Liu, Z., Cong, Y., Brasier, A. R., Pinchuk, I. V., Tian, B., & Zhou, J. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izab190 · Cited by 45 · see citing works
da Silva, G. B., Manica, D., da Silva, A. P., Kosvoski, G. C., Hanauer, M. C., Assmann, C. E., Simões, J. L. B., Pillat, M. M., de Lara, J. D., Marafon, F., et al. (2022) · Journal of Molecular Medicine · doi:10.1007/s00109-022-02185-4 · Cited by 44 · see citing works
P2X7 promotes the progression of MLL-AF9 induced acute myeloid leukemia by upregulation of Pbx3
Feng, W., Yang, X. Q., Wang, L., Wang, R., Yang, F., Wang, H., Liu, X., Ren, Q., Zhang, Y., Zhu, X., et al. (2020) · Haematologica · doi:10.3324/haematol.2019.243360 · Cited by 44 · see citing works
P2X7 receptor antagonism inhibits tumour growth in human high-grade gliomas
Kan, L. K., Seneviratne, S. O., Drummond, K. J., Williams, D. A., O'Brien, T. J., & Monif, M. (2020) · Purinergic Signalling · doi:10.1007/s11302-020-09705-2 · Cited by 46 · see citing works
P2X7 receptor: a critical regulator and potential target for breast cancer
Zhu, X., Li, Q., Song, W., Peng, X., & Zhao, R. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-021-02041-x · Cited by 43 · see citing works
The Role of ATP Receptors in Pain Signaling
Inoue, K. (2022) · Neurochemical Research · doi:10.1007/s11064-021-03516-6 · Cited by 42 · see citing works
The P2X7 Receptor Is Shed Into Circulation: Correlation With C-Reactive Protein Levels
Giuliani, A. L., Berchan, M., Sanz, J. M., Passaro, A., Pizzicotti, S., Vultaggio-Poma, V., Sarti, A. C., & Virgilio, F. D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00793 · Cited by 42 · see citing works
Molecular Pharmacology of P2X Receptors: Exploring Druggable Domains Revealed by Structural Biology
Oken, A. C., Krishnamurthy, I., Savage, J. C., Lisi, N. E., Godsey, M., & Mansoor, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.925880 · Cited by 41 · see citing works
P2X receptors in cancer growth and progression
Virgilio, F. D., Vultaggio-Poma, V., & Sarti, A. C. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114350 · Cited by 41 · see citing works
Purinergic signaling and tumor microenvironment in cervical Cancer
Pfaffenzeller, M. S., Franciosi, M. L. M., & Cardoso, A. M. (2020) · Purinergic Signalling · doi:10.1007/s11302-020-09693-3 · Cited by 39 · see citing works
P2 Purinergic Signaling in the Distal Lung in Health and Disease
Wirsching, E., Fauler, M., Fois, G., & Frick, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144973 · Cited by 40 · see citing works
Cytokines and Their Genetic Polymorphisms Related to Periodontal Disease
Kozak, M., Dąbrowska‐Żamojcin, E., Mazurek−Mochol, M., & Pawlik, A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9124045 · Cited by 38 · see citing works
Bernardazzi, C., Castelo-Branco, M. T. L., Pêgo, B., Ribeiro, B. E., Rosas, S. L. B., Santana, P. T., Machado, J. C., Leal, C. V., Thompson, F. L., Coutinho‐Silva, R., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094616 · Cited by 38 · see citing works
Purinergic P2X7 Receptor: A Cation Channel Sensitive to Tumor Microenvironment
Scarpellino, G., Genova, T., & Munaron, L. (2019) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574892814666190116122256 · Cited by 36 · see citing works
The role of microglia and P2X7 receptors in gliomas
Kan, L. K., Williams, D. J., Drummond, K. J., O'Brien, T. J., & Monif, M. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.04.010 · Cited by 35 · see citing works
The P2X7 purinergic receptor: a potential therapeutic target for lung cancer
Li, Q., Zhu, X., Song, W., Peng, X., & Zhao, R. (2020) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-020-03379-4 · Cited by 36 · see citing works
To Inhibit or Enhance? Is There a Benefit to Positive Allosteric Modulation of P2X Receptors?
Stokes, L., Bidula, S. M., Bibič, L., & Allum, E. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00627 · Cited by 35 · see citing works
Possible role of purinergic signaling in COVID-19
Franciosi, M. L. M., Lima, M. D. M., Schetinger, M. R. C., & Cardoso, A. M. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04130-4 · Cited by 35 · see citing works
FTY720 in CNS injuries: Molecular mechanisms and therapeutic potential
Zhang, L., & Wang, H. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.08.013 · Cited by 34 · see citing works
Cui, Z., Wang, G., Zhang, J., Song, J., Jiang, Y., Dou, J., Lian, L., Nan, J., & Wu, Y. (2021) · Phytotherapy Research · doi:10.1002/ptr.7214 · Cited by 34 · see citing works
Ernest James Phillips, T., & Maguire, E. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.652593 · Cited by 33 · see citing works
Loss of P2X7 receptor function dampens whole body energy expenditure and fatty acid oxidation
Giacovazzo, G., Apolloni, S., & Coccurello, R. (2018) · Purinergic Signalling · doi:10.1007/s11302-018-9610-y · Cited by 32 · see citing works
Liu, X., Xie, Z., Li, S., He, J., Cao, S., & Xiao, Z. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59032 · Cited by 33 · see citing works
Zhang, W. (2021) · Purinergic Signalling · doi:10.1007/s11302-020-09761-8 · Cited by 31 · see citing works
Zhan, T., Tang, S., Du, J., Liu, J., Yu, B., Yang, Y., Xie, Y., Qiu, Y., Li, G., & Gao, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021186 · Cited by 30 · see citing works
P2RX7 at the Host-Pathogen Interface of Infectious Diseases
Soare, A., Freeman, T. L., Min, A. K., Malik, H. S., Osota, E. O., & Swartz, T. H. (2021) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00055-20 · Cited by 25 · see citing works
Cancer Metabostemness and Metabolic Reprogramming via P2X7 Receptor
Rabelo, I. L. A., Arnaud-Sampaio, V. F., Adinolfi, E., Ulrich, H., & Lameu, C. (2021) · Cells · doi:10.3390/cells10071782 · Cited by 30 · see citing works
A promising independent prognostic biomarker in colorectal cancer: P2X7 receptor.
Çalık, İ., Çalık, M., Turken, G., & Özercan, İ. H. (2020) · PubMed Central · Cited by 29 · see citing works
Solini, A., Rossi, C., Santini, E., Giuntini, M., Raggi, F., Parolini, F., Biancalana, E., Prete, E. D., Bonuccelli, U., & Ceravolo, R. (2021) · European Journal of Neurology · doi:10.1111/ene.14918 · Cited by 29 · see citing works
P2 Receptors as Therapeutic Targets in the Salivary Gland: From Physiology to Dysfunction
Khalafalla, M. G., Woods, L. T., Jasmer, K. J., Forti, K. M., Camden, J. M., Jensen, J. L., Limesand, K. H., Galtung, H. K., & Weisman, G. A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00222 · Cited by 28 · see citing works
Potential Therapeutic Role of Purinergic Receptors in Cardiovascular Disease Mediated by SARS‐CoV‐2
dos Anjos, F., Simões, J. L. B., Assmann, C. E., Carvalho, F. B., & Bagatini, M. D. (2020) · Journal of Immunology Research · doi:10.1155/2020/8632048 · Cited by 29 · see citing works
Spotlight on P2X7 Receptor PET Imaging: A Bright Target or a Failing Star?
Schmidt, S., Isaak, A., & Junker, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021374 · Cited by 28 · see citing works
P2X7 purinoceptor as a therapeutic target in muscular dystrophies
Górecki, D. C. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.02.003 · Cited by 28 · see citing works
Purinergic Calcium Signals in Tumor-Derived Endothelium
Scarpellino, G., Genova, T., Avanzato, D., Bernardini, M., Bianco, S., Petrillo, S., Tolosano, E., Vieira, J. R. D. A., Bussolati, B., Fiorio, A., et al. (2019) · Cancers · doi:10.3390/cancers11060766 · Cited by 28 · see citing works
Oken, A. C., Lisi, N. E., Krishnamurthy, I., McCarthy, A. E., Godsey, M., Glasfeld, A., & Mansoor, S. (2024) · Nature Communications · doi:10.1038/s41467-024-50771-6 · Cited by 27 · see citing works
Sun, H. J., Xin, Y., Wu, J., ShuQin, Z., GuiLian, Z., Wu, H., Zhen, G., HongWei, R., & Yongnan, L. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104773 · Cited by 27 · see citing works
Strassheim, D., Karoor, V., Stenmark, K. R., Verin, A. D., & Gerasimovskaya, E. V. (2018) · Vessel Plus · doi:10.20517/2574-1209.2018.44 · Cited by 26 · see citing works
Ca2+ as a therapeutic target in cancer
Gross, S., Mallu, P., Joshi, H., Schultz, B. M., Go, C. K., & Soboloff, J. (2020) · Advances in cancer research · doi:10.1016/bs.acr.2020.05.003 · Cited by 28 · see citing works
Li, P., Zhang, Q., Xiao, Z., Yu, S., Yan, Y., & Qin, Y. (2018) · Molecular Pain · doi:10.1177/1744806918803039 · Cited by 26 · see citing works
Doǧan, E., Aygün, H., Arslan, G., Rzayev, E., Avcı, B., Ayyıldız, M., & Ağar, E. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00414 · Cited by 26 · see citing works
Bando, K., Kuroishi, T., Tada, H., Oizumi, T., Tanaka, Y., Takahashi, T., Mizoguchi, I., Sugawara, S., & Endo, Y. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4384 · Cited by 24 · see citing works
Wang, K., Sun, M., Juan, Z., Zhang, J., Sun, Y., Wang, G., Wang, C., Li, Y., Kong, W., Fan, L., et al. (2022) · Behavioural Neurology · doi:10.1155/2022/3777351 · Cited by 24 · see citing works
Purinergic Signaling in Pancreas—From Physiology to Therapeutic Strategies in Pancreatic Cancer
Novak, I., Yu, H., Magni, L., & Deshar, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228781 · Cited by 24 · see citing works
Photobiomodulation inhibits inflammation in the temporomandibular joint of rats
Pereira, E. D. S. B. M., Basting, R. T., Abdalla, H. B., Garcez, A. S., Napimoga, M. H., & Clemente‐Napimoga, J. T. (2021) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2021.112281 · Cited by 24 · see citing works
P2X 7 receptors exhibit at least three modes of allosteric antagonism
Oken, A. C., Ditter, I. A., Lisi, N. E., Krishnamurthy, I., Godsey, M., & Mansoor, S. (2024) · Science Advances · doi:10.1126/sciadv.ado5084 · Cited by 23 · see citing works
eATP/P2X7R Axis: An Orchestrated Pathway Triggering Inflammasome Activation in Muscle Diseases
Panicucci, C., Raffaghello, L., Bruzzone, S., Baratto, S., Principi, E., Minetti, C., Gazzerro, E., & Bruno, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21175963 · Cited by 24 · see citing works
P2RX7 promotes osteosarcoma progression and glucose metabolism by enhancing c-Myc stabilization
Sheng, G., Gao, Y., Ding, Q., Zhang, R., Wang, T., Jing, S., Zhao, H., Ma, T., Wu, H. K., & Yang, Y. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03985-z · Cited by 24 · see citing works
P2X7R as an independent prognostic indicator in gastric cancer
Çalık, İ., Çalık, M., Sarıkaya, B., Özercan, İ. H., Arslan, R., Artaş, G., & Dağlı, A. F. (2020) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2020.4620 · Cited by 23 · see citing works
Santana, P. T., de Lima, I. S., Souza, K. C. D. S. E., Barbosa, P. H. S., & de Souza, H. S. P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252010874 · Cited by 23 · see citing works
Emerging Roles of Cells and Molecules of Innate Immunity in Alzheimer’s Disease
Tamburini, B., Badami, G. D., Manna, M. P. L., Azgomi, M. S., Caccamo, N., & Dieli, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241511922 · Cited by 22 · see citing works
P2X7 Receptor: an Emerging Target in Alzheimer’s Disease
Huang, Q., Ying, J., Yu, W., Dong, Y., Xiong, H., Zhang, Y., Liu, J., Wang, X., & Hua, F. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03699-9 · Cited by 22 · see citing works
Arylboronic acids inhibit P2X7 receptor function and the acute inflammatory response
Faria, R. X., Hiller, N. D. J., Salles, J. P., Resende, J. A. L. C., Diogo, R. T., von Ranke, N. L., Bello, M. L., Rodrigues, C. R., Castro, H. C., & Martins, D. D. L. (2019) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-019-09802-x · Cited by 22 · see citing works
Radioligands targeting purinergic P2X7 receptor
Zheng, Q. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127169 · Cited by 22 · see citing works
Bijelić, D. D., Milicevic, K. D., Lazarević, M. N., Miljković, D. M., Pristov, J. B., Savić, D. Z., Petković, B. B., Anđjus, P. R., Momčilović, M. B., & Nikolic, L. M. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24699 · Cited by 22 · see citing works
Pandey, S. N., Babu, M. A., Goyal, K., Menon, S. V., Ray, S., Kaur, M., Sharma, S., Rana, M., Rekha, A., Ali, H., et al. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01926-4 · Cited by 21 · see citing works
P2X7 receptor inhibition by 2-amino-3-aryl-1,4-naphthoquinones
Martins, D. D. L., Borges, A. A., Silva, N. A. D. A. E., Faria, J. V., Hoelz, L. V. B., de Souza, H. V. C. M., Bello, M. L., Boechat, N., Ferreira, V. F., & Faria, R. X. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104278 · Cited by 20 · see citing works
Mishra, A., Behura, A., Kumar, A., Ghosh, A., Naik, L., Mawatwal, S., Mohanty, S. S., Mishra, A., Saha, S., Bhutia, S. K., et al. (2020) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2020.129806 · Cited by 20 · see citing works
Apolloni, S., Fabbrizio, P., Amadio, S., Napoli, G., Freschi, M., Sironi, F. M., Pevarello, P., Tarroni, P., Liberati, C., Bendotti, C., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910649 · Cited by 21 · see citing works
- Authors
- Burnstock, G., & Knight, G. E.
- Affiliations
- The University of Melbourne (AU)
- University College London (GB)
- Corresponding author
- Burnstock, Geoffrey
- ORCID
- Burnstock, Geoffrey
- Venue
- Purinergic Signalling
- Published
- 2017-11-21
- Volume
- 14
- Issue
- 1
- Pages
- 1-18
- ISSN
- 1573-9538 (ISSN-L)
- 1573-9546
- PMC
- PMC5842154
- OpenAlex
- W2768734810
- Semantic Scholar
- 1aa37d0f163277fbeb968b6bb8cea0a8afcbe622
- Cited by
- 248
- References
- 228
- Citations by year
- 2026: 13 · 2025: 20 · 2024: 22 · 2023: 25 · 2022: 28 · 2021: 48 · 2020: 52 · 2019: 27 · 2018: 13
- FWCI
- 2.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Purinergic Signalling (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Funders
- University College London (UCL)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Health Sciences › Medicine › Physiology › Pain Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
- Keywords
- P2X7 receptor, ATP, P2X7 receptor antagonists, inflammation, tumor progression, apoptosis, neurodegenerative diseases, mental illness, epilepsy, therapeutic target
- MeSH terms
- Animals, Humans, Inflammation, Neoplasms, Disease Progression, Receptors, Purinergic P2X7, Purinergic P2X Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review